A41V (p.Ala41Val) variant of SLC35A2 (UDP-galactose translocator)

A41V (p.Ala41Val) in SLC35A2 (UDP-galactose translocator) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.08 / 1. The record also includes population frequency data and structural context.

A41V (p.Ala41Val) variant details